Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Gallbladder Neoplasms × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Gallbladder Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 4 Capecitabine 3 spartalizumab 1 pembrolizumab 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Ondansetron 1 Dexamethasone 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03260712 2023-11-03

Pembrolizumab in Biliary Tract Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡